Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

The aim of this study is to explore the kidney-specific adaptive immune landscape in patients with active LN at the single-cell ... of the major factors of morbidity and mortality in systemic lupus ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease ... Clinical Remission: Clinically quiescent but serologically active disease, with high levels of serological markers ...

Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

A study reveals caffeine's potential to enhance heart health by improving endothelial function in systemic lupus ...

The clinical hold doesn’t cover its drug’s Investigational New Drug application for autoimmune hepatitis, for which the Phase ...